<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Markets | Leocyte Focus Regions</title>
    <meta name="description" content="Deep expertise in pharmaceutical markets including India, Brazil, Portugal, Mexico, and Colombia with localized regulatory and commercial insights.">
    <link rel="stylesheet" href="assets/css/styles.css">
</head>
<body>
    <header class="header">
        <nav class="nav container">
            <a href="index.html" class="nav__logo">Leocyte</a>
            <ul class="nav__menu">
                <li><a href="about.html">About</a></li>
                <li><a href="services.html">Services</a></li>
                <li><a href="markets.html">Markets</a></li>
                <li><a href="privacy.html">Privacy</a></li>
                <li><a href="index.html#contact" class="button button--small">Contact</a></li>
            </ul>
            <button class="nav__toggle" aria-label="Toggle menu">
                <span></span>
                <span></span>
                <span></span>
            </button>
        </nav>
    </header>

    <main>
        <section class="page-hero">
            <div class="container">
                <h1>Strategic Market Focus</h1>
                <p>Deep local expertise across high-growth pharmaceutical markets with unique regulatory landscapes and partnership opportunities.</p>
            </div>
        </section>

        <section class="markets-detail">
            <div class="container">
                <div class="market-profile">
                    <h2>India</h2>
                    <div class="market-stats">
                        <div class="stat">
                            <strong>Market Size:</strong> $25B+
                        </div>
                        <div class="stat">
                            <strong>Growth Rate:</strong> 9% CAGR
                        </div>
                        <div class="stat">
                            <strong>Key Opportunity:</strong> Generics manufacturing, biosimilars, digital health
                        </div>
                    </div>
                    <div class="market-content">
                        <h3>Regulatory Landscape</h3>
                        <p>Central Drugs Standard Control Organization (CDSCO) oversight with evolving pathways for innovative therapies. Price controls apply to essential medicines under NLEM.</p>
                        
                        <h3>Partnership Opportunities</h3>
                        <ul>
                            <li>Contract development and manufacturing (CDMO)</li>
                            <li>Biosimilar development and commercialization</li>
                            <li>Local distribution partnerships</li>
                            <li>Digital health and telemedicine collaborations</li>
                        </ul>
                        
                        <div class="market-insight">
                            <h4>Strategic Insight</h4>
                            <p>India's production-linked incentive (PLI) scheme creates attractive opportunities for manufacturing partnerships, while growing middle-class demand drives innovative therapy adoption.</p>
                        </div>
                    </div>
                </div>

                <div class="market-profile">
                    <h2>Brazil</h2>
                    <div class="market-stats">
                        <div class="stat">
                            <strong>Market Size:</strong> $30B+
                        </div>
                        <div class="stat">
                            <strong>Growth Rate:</strong> 7% CAGR
                        </div>
                        <div class="stat">
                            <strong>Key Opportunity:</strong> Universal healthcare access, specialty medicines
                        </div>
                    </div>
                    <div class="market-content">
                        <h3>Regulatory Landscape</h3>
                        <p>ANVISA regulation with health technology assessment by CONITEC. Complex pricing and reimbursement environment with federal and state-level purchasing.</p>
                        
                        <h3>Partnership Opportunities</h3>
                        <ul>
                            <li>Local manufacturing to access public tenders</li>
                            <li>Specialty product distribution partnerships</li>
                            <li>Clinical research collaborations</li>
                            <li>Public-private partnership models</li>
                        </ul>
                        
                        <div class="market-insight">
                            <h4>Strategic Insight</h4>
                            <p>Brazil's SUS (Sistema Único de Saúde) represents massive purchasing power but requires local presence and price competitiveness. Strategic partnerships can navigate price-volume tradeoffs.</p>
                        </div>
                    </div>
                </div>

                <div class="market-profile">
                    <h2>Portugal</h2>
                    <div class="market-stats">
                        <div class="stat">
                            <strong>Market Size:</strong> $4B+
                        </div>
                        <div class="stat">
                            <strong>Growth Rate:</strong> 4% CAGR
                        </div>
                        <div class="stat">
                            <strong>Key Opportunity:</strong> EU gateway, clinical research hub
                        </div>
                    </div>
                    <div class="market-content">
                        <h3>Regulatory Landscape</h3>
                        <p>INFARMED regulation with EMA alignment. Price and reimbursement decisions influenced by HTA and budget impact assessments.</p>
                        
                        <h3>Partnership Opportunities</h3>
                        <ul>
                            <li>EU market entry strategy</li>
                            <li>Clinical trial site partnerships</li>
                            <li>Distribution and commercialization</li>
                            <li>Real-world evidence generation</li>
                        </ul>
                        
                        <div class="market-insight">
                            <h4>Strategic Insight</h4>
                            <p>Portugal offers efficient EU regulatory pathways and competitive clinical trial costs while serving as strategic gateway to Portuguese-speaking markets including Brazil and Angola.</p>
                        </div>
                    </div>
                </div>

                <div class="market-profile">
                    <h2>Mexico</h2>
                    <div class="market-stats">
                        <div class="stat">
                            <strong>Market Size:</strong> $12B+
                        </div>
                        <div class="stat">
                            <strong>Growth Rate:</strong> 6% CAGR
                        </div>
                        <div class="stat">
                            <strong>Key Opportunity:</strong> Manufacturing for US market, growing private insurance
                        </div>
                    </div>
                    <div class="market-content">
                        <h3>Regulatory Landscape</h3>
                        <p>COFEPRIS regulation with US FDA alignment advantages. Segmented market with public sector (IMSS, ISSSTE) and growing private insurance coverage.</p>
                        
                        <h3>Partnership Opportunities</h3>
                        <ul>
                            <li>US-focused manufacturing partnerships</li>
                            <li>Private sector distribution</li>
                            <li>Specialty product commercialization</li>
                            <li>Nearshoring manufacturing strategies</li>
                        </ul>
                        
                        <div class="market-insight">
                            <h4>Strategic Insight</h4>
                            <p>Mexico's USMCA membership creates manufacturing advantages for US market access, while growing private insurance expands innovative therapy market potential beyond public sector limitations.</p>
                        </div>
                    </div>
                </div>

                <div class="market-profile">
                    <h2>Colombia</h2>
                    <div class="market-stats">
                        <div class="stat">
                            <strong>Market Size:</strong> $5B+
                        </div>
                        <div class="stat">
                            <strong>Growth Rate:</strong> 8% CAGR
                        </div>
                        <div class="stat">
                            <strong>Key Opportunity:</strong> Regulatory sophistication, Andean region hub
                        </div>
                    </div>
                    <div class="market-content">
                        <h3>Regulatory Landscape</h3>
                        <p>INVIMA regulation with evolving HTA framework. Unified health system (SISBEN) with growing capacity for innovative therapy funding.</p>
                        
                        <h3>Partnership Opportunities</h3>
                        <ul>
                            <li>Andean region distribution hub</li>
                            <li>Market access strategy development</li>
                            <li>Public sector tender partnerships</li>
                            <li>Regional clinical research</li>
                        </ul>
                        
                        <div class="market-insight">
                            <h4>Strategic Insight</h4>
                            <p>Colombia's stable regulatory environment and strategic location make it ideal for Andean region expansion, with growing HTA sophistication enabling evidence-based market access strategies.</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section class="cta-section">
            <div class="container">
                <h2>Access Our Market Intelligence</h2>
                <p>Get detailed market reports and partnership opportunities specific to your therapeutic focus.</p>
                <a href="index.html#contact" class="button button--large">Talk to our market leads</a>
            </div>
        </section>
    </main>

    <footer class="footer">
        <div class="container">
            <div class="footer__content">
                <div class="footer__section">
                    <h3>Leocyte</h3>
                    <p>Strategic pharmaceutical business development and licensing partners for emerging markets.</p>
                </div>
                <div class="footer__section">
                    <h4>Contact</h4>
                    <p>Email: <a href="mailto:AlloAllo@leocyte.com">AlloAllo@leocyte.com</a></p>
                    <p><a href="assets/Leocyte_CAPABILITIES.pdf" download>Download Capabilities PDF</a></p>
                </div>
                <div class="footer__section">
                    <h4>Legal</h4>
                    <p><a href="privacy.html">Privacy Policy</a></p>
                    <p><a href="#" class="do-not-sell">Do Not Sell My Personal Information</a></p>
                </div>
            </div>
            <div class="footer__bottom">
                <p>&copy; 2024 Leocyte. All rights reserved.</p>
            </div>
        </div>
    </footer>

    <script src="cookie-consent.js"></script>
    <script>
        // Mobile menu toggle
        document.querySelector('.nav__toggle').addEventListener('click', function() {
            document.querySelector('.nav__menu').classList.toggle('nav__menu--open');
        });
    </script>
</body>
</html>
